MAPK, mitogen-activated protein kinase
“Docking Studies on Eupalitin-3-O-β-D-galactopyranoside as Potential Inhibitor of Cyprinus carpio (KOI CARP) MAPK/ERK Kinase 2 and Mitogen-Activated Protein Kinase (p38)” by Kader Asen Fathima, Chetancherry Somasundaram Parameswari, India.
6
Flavonoids in modulation of cell survival signalling pathways
9
Emerging treatment options to improve cardiovascular outcomes in patients with acute coronary syndrome: focus on losmapimod
8
Regulation of the mitogen activated protein kinase p44 ERK activity during anoxia/recovery in rainbow trout hypodermal fibroblasts
12
Identification and Characterization of MAPK Phosphorylation Sites in Runx2
83
Identification of Top-ranked Proteins within a Directional Protein Interaction Network using the PageRank Algorithm: Applications in Humans and Plants
17
Leptin receptors
5
Mitogen-activated protein kinase phosphatase-3 (MKP-3) in the surgical wound is necessary for the resolution of postoperative pain in mice
12
The Aspergillus fumigatus Mucin MsbA Regulates the Cell Wall Integrity Pathway and Controls Recognition of the Fungus by the Immune System
15
Cochliobolus heterostrophus T toxin gene expression modulation via G protein and MAPK pathways
8
Suppressors of a Saccharomyces cerevisiae pkc1 mutation identify alleles of the phosphatase gene PTC1 and of a novel gene encoding a putative basic leucine zipper protein.
11
Kinase Activity Profiling of Gram-Negative Pneumonia
7
From mouth to macrophage: mechanisms of innate immune subversion by Mycobacterium avium subsp. paratuberculosis
15
Mitogen-Activated Protein Kinases Regulate LSF Occupancy at the Human Immunodeficiency Virus Type 1 Promoter
11
Screening of potential diagnostic markers and therapeutic targets against colorectal cancer
9
Role and regulation of MKP-1 in airway inflammation
12
Essential role of mitogen activated protein kinases in IL 17A induced MMP 3 expression in human synovial sarcoma cells
9
Original Article Tumor suppressor BLU exerts growth inhibition by blocking ERK signaling and disrupting cell cycle progression through RAS pathway interference
11
MAP3K1 May be a Promising Susceptibility Gene for Type 2 Diabetes Mellitus in an Iranian Population
7
Glucocorticoid insensitivity as a future target of therapy for chronic obstructive pulmonary disease
13